Hepalink Secures SAHPRA Approval for Ivenoxin in South Africa
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (SHE: 002399, HKG: 9989) has announced that it has...
Product approvals
Akeso’s Penpulimab Gains FDA Approval for Nasopharyngeal Carcinoma Treatment
China-based Akeso, Inc. (HKG: 9926) announced that it has received marketing approval from the US...
Roche Launches Navify Chest Pain Triage Algorithm With CE Mark
Swiss healthcare giant Roche (SWX: ROG, OTCMKTS: RHHBY) announced today that it has received CE...
MicroPort MedBot Gains NMPA Clearance for Toumai’s Remote Surgery Across Departments
Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) has announced receiving clearance from China’s National...
Grand Pharma Secures NMPA Approval for Fluticasone Nasal Spray
China-based Grand Pharmaceutical Group Co., Ltd. (HKG: 0512) has obtained marketing authorization from China’s National...
Novocure Wins CE Mark for Optune Lua in Metastatic NSCLC Treatment
Switzerland-based Novocure (NASDAQ: NVCR), the developer of Tumor Treating Fields (TTFields) for cancer therapy, has...
BMS Secures NMPA Approval for Opdivo in Resectable NSCLC Neoadjuvant Therapy
Bristol-Myers Squibb (BMS, NYSE: BMY) has announced additional indication approval from China’s National Medical Products...
AstraZeneca’s Ultomiris Approved in China for Generalized Myasthenia Gravis
UK-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) has announced that the National Medical Products Administration (NMPA)...
Broncus Medical Secures NMPA Approval for BroncAblate in Lung Cancer Treatment
Broncus Medical Inc. (HKG: 2216), a provider of precision intervention solutions for lung disease, announced...
Akeso’s Ebdarokimab Receives NMPA Approval for Moderate to Severe Plaque Psoriasis
China’s Akeso Biopharma (HKG: 9926) announced that it has received marketing approval from the National...
Vivolight’s Multimodal Coronary OCT System Gains FDA Clearance
Shenzhen-based minimally invasive laser medical device firm Vivolight Medical Device & Technology Co., Ltd has...
Sanofi’s Dupixent Approved by FDA for Chronic Spontaneous Urticaria
France-based pharmaceutical major Sanofi (EPA: SAN, NASDAQ: SNY) has announced that the US Food and Drug...
Medtronic Wins FDA Approval for Simplera Sync Sensor in MiniMed 780G System
US-Irish medical technology firm Medtronic plc (NYSE: MDT) has secured marketing approval from the US...
AstraZeneca’s Truqap Granted NMPA Approval for Breast Cancer Treatment
China’s National Medical Products Administration (NMPA) has approved AstraZeneca’s (AZ, NASDAQ: AZN) Truqap (capivasertib) for...
Medtronic’s Implantable Defibrillator System Gains NMPA Approval in China
China’s National Medical Products Administration (NMPA) has approved Medtronic’s (NYSE: MDT) endovascular implantable defibrillation electrode...
GSK’s Blenrep Approved by UK MHRA for Multiple Myeloma Treatment
UK-based pharmaceutical giant UK-based pharmaceutical company GlaxoSmithKline (GSK, NYSE: GSK) has announced the receipt of...
Eisai and Biogen Win EU Approval for Leqembi in Early Alzheimer’s Disease
Eisai Co., Ltd. (TYO: 4523) and Biogen Inc. (NASDAQ: BIIB) jointly announced that they have...
Edwards Lifesciences Gains EU CE Mark for SAPIEN M3 Mitral Valve System
US medical device giant Edwards Lifesciences Corporation (NYSE: EW) has announced that it has received...
Roche’s Columvi Approved by EC for Relapsed DLBCL Treatment in Europe
Swiss pharmaceutical giant Roche (SWX: ROG, OTCMKTS: RHHBY) has announced that it has received marketing...
MSD’s Gardasil 9 Approved in China for Males Aged 16 to 26
US pharmaceutical major Merck, Sharp & Dohme (MSD; NYSE: MRK) has announced marketing approval from...